S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

NRIX Nurix Therapeutics Inc

16.33

-0.53 (-3.14%)

07 Jun 2024 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Nurix Therapeutics (NASDAQ:NRIX)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Nurix Therapeutics Charts.

Nurix Therapeutics (NASDAQ:NRIX)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Nurix Therapeutics Charts.

Nurix Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 June 2024 (1 day ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 June 2024 (3 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 4 June 2024 (3 days ago) • Edgar (US Regulatory)

Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference
Wednesday 29 May 2024 (1 week ago) • GlobeNewswire Inc.

Nurix Therapeutics Appoints Paula G. O’Connor, M.D., as Chief Medical Officer and Pasit Phiasivongsa, Ph.D., as Chief Technical Officer
Tuesday 28 May 2024 (1 week ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 21 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 21 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 21 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Nurix Therapeutics Announces Board Chair Transition
Tuesday 21 May 2024 (2 weeks ago) • GlobeNewswire Inc.

Nurix Therapeutics Announces Upcoming Oral Presentation of New Data from Ongoing Clinical Trial of NX-5948, a Selective Bruton’s Tyrosine Kinase (BTK) Degrader, at the European Hematology Association Congress (EHA2024)
Wednesday 15 May 2024 (3 weeks ago) • GlobeNewswire Inc.

Nurix Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference
Tuesday 7 May 2024 (1 month ago) • GlobeNewswire Inc.

Nurix Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Wednesday 17 April 2024 (2 months ago) • GlobeNewswire Inc.

More Nurix Therapeutics Inc News Articles

NLBNPIT1ZPM1 20241220 200

Quarzo Fx 4.5% Apr42 Amo...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions